Mandate

Vinge advises Statoil in connection with transaction concerning Lundin Petroleum and International Petroleum Corporation

Vinge advises Statoil ASA (“Statoil”) in connection with a transaction concerning Lundin Petroleum AB (publ) (“Lundin Petroleum”) and International Petroleum Corporation (“IPC”). The board of Lundin Petroleum has proposed to spin-off certain assets outside of Norway into a newly incorporated company, IPC, and to distribute the shares in IPC as dividend in kind to the shareholders of Lundin Petroleum. The intention is to list the shares of IPC on the Toronto Stock Exchange and Nasdaq Stockholm.

Further, the board of IPC has approved that a subsidiary to IPC, after the separate listing, submits a repurchase offer to all shareholders in IPC to acquire shares. Statoil has informed about its intention to sell its shareholding in IPC in the repurchase offer and Statoil has also entered into an agreement with Nemesia, an investment company related to the Lundin family, to sell any remaining shares held by Statoil in IPC to Nemesia which have not been sold through the repurchase offer.

Vinge’s team consists of Dain Hård Nevonen, Göran Nyström and Rikard Lindahl.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026